Raymond James & Associates’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-13,897
| Closed | -$98K | – | 4030 |
|
|
2021
Q1 | $98K | Buy |
+13,897
| New | +$98K | ﹤0.01% | 3716 |
|
|
2017
Q3 | – | Sell |
-7,581
| Closed | -$710K | – | 3339 |
|
|
2017
Q2 | $710K | Buy |
7,581
+3,102
| +69% | +$291K | ﹤0.01% | 2227 |
|
|
2017
Q1 | $285K | Sell |
4,479
-2,544
| -36% | -$162K | ﹤0.01% | 2712 |
|
|
2016
Q4 | $312K | Buy |
7,023
+773
| +12% | +$34.3K | ﹤0.01% | 2588 |
|
|
2016
Q3 | $225K | Buy |
+6,250
| New | +$225K | ﹤0.01% | 2777 |
|